Nina Thomas

410 total citations
11 papers, 306 citations indexed

About

Nina Thomas is a scholar working on Pathology and Forensic Medicine, Rheumatology and Health. According to data from OpenAlex, Nina Thomas has authored 11 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 3 papers in Rheumatology and 2 papers in Health. Recurrent topics in Nina Thomas's work include Multiple Sclerosis Research Studies (8 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Vaccine Coverage and Hesitancy (2 papers). Nina Thomas is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Vaccine Coverage and Hesitancy (2 papers). Nina Thomas collaborates with scholars based in United States, Canada and Germany. Nina Thomas's co-authors include Suellen M. Curkendall, Paul Juneau, Kelly Bell, Audrey J Weiss, Tuula Tyry, Amber Salter, Ruth Ann Marrie, Gary Cutter, Robert J. Fox and Carol Mansfield and has published in prestigious journals such as Multiple Sclerosis Journal, Clinical Therapeutics and Value in Health.

In The Last Decade

Nina Thomas

11 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nina Thomas United States	9	161	79	70	48	38	11	306
Hélène Parisé United States	8	52 0.3×	13 0.2×	48 0.7×	34 0.7×	21 0.6×	23	290
Dana Stafkey-Mailey United States	9	27 0.2×	61 0.8×	19 0.3×	41 0.9×	29 0.8×	28	296
Lillian Wang United States	8	72 0.4×	10 0.1×	49 0.7×	56 1.2×	93 2.4×	15	579
Michael Doherty United States	4	17 0.1×	37 0.5×	38 0.5×	96 2.0×	43 1.1×	7	403
F. Stam Netherlands	8	127 0.8×	15 0.2×	17 0.2×	9 0.2×	12 0.3×	13	364
Lisbeth M. Baggesen Denmark	11	74 0.5×	6 0.1×	191 2.7×	12 0.3×	13 0.3×	13	450
Debra Wertz United States	12	36 0.2×	23 0.3×	53 0.8×	102 2.1×	9 0.2×	24	369
Antonella Pedrini Italy	9	34 0.2×	7 0.1×	20 0.3×	46 1.0×	15 0.4×	50	248
G. Schiffhorst Germany	10	46 0.3×	8 0.1×	27 0.4×	36 0.8×	25 0.7×	30	289
Rachel Bergman United States	4	85 0.5×	9 0.1×	16 0.2×	33 0.7×	25 0.7×	5	351

Countries citing papers authored by Nina Thomas

Since Specialization

Citations

This map shows the geographic impact of Nina Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Thomas more than expected).

Fields of papers citing papers by Nina Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Thomas. The network helps show where Nina Thomas may publish in the future.

Co-authorship network of co-authors of Nina Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Thomas. A scholar is included among the top collaborators of Nina Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Thomas. Nina Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Bron, Morgan, et al.. (2025). Utility and limitations of the FDA adverse events reporting system public dashboard for safety analyses: a case study with vesicular monoamine transporter 2 inhibitors. Expert Opinion on Drug Safety. 1–6. 1 indexed citations

Visaria, Jay, Nina Thomas, Tao Gu, Joseph Singer, & Hiangkiat Tan. (2018). Understanding the Patient's Journey in the Diagnosis and Treatment of Multiple Sclerosis in Clinical Practice. Clinical Therapeutics. 40(6). 926–939. 9 indexed citations

Yang, Hongbo, et al.. (2017). Cost-effectiveness analysis of ocrelizumab versus subcutaneous interferon beta-1a for the treatment of relapsing multiple sclerosis. Journal of Medical Economics. 20(10). 1056–1065. 25 indexed citations

Frasco, Melissa A., et al.. (2017). Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferonβ-1a. Journal of Medical Economics. 20(10). 1074–1082. 13 indexed citations

Cofield, Stacey S., Nina Thomas, Tuula Tyry, Robert J. Fox, & Amber Salter. (2017). Shared Decision Making and Autonomy Among US Participants with Multiple Sclerosis in the NARCOMS Registry. International Journal of MS Care. 19(6). 303–312. 27 indexed citations

Salter, Amber, Nina Thomas, Tuula Tyry, Gary Cutter, & Ruth Ann Marrie. (2017). A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry. Multiple Sclerosis Journal. 24(7). 951–962. 11 indexed citations

Salter, Amber, Nina Thomas, Tuula Tyry, Gary Cutter, & Ruth Ann Marrie. (2016). Employment and absenteeism in working-age persons with multiple sclerosis. Journal of Medical Economics. 20(5). 493–502. 55 indexed citations

Mansfield, Carol, et al.. (2016). Preferences for Multiple Sclerosis Treatments. International Journal of MS Care. 19(4). 172–183. 24 indexed citations

Thomas, Nina, et al.. (2015). Us Rrms Patient Preferences for Multiple Sclerosis Treatments: An Online Survey. Value in Health. 18(7). A761–A761. 1 indexed citations

10.

Thomas, Nina, et al.. (2015). The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis. Journal of Medical Economics. 19(5). 497–505. 27 indexed citations

11.

Curkendall, Suellen M., Nina Thomas, Kelly Bell, Paul Juneau, & Audrey J Weiss. (2013). Predictors of medication adherence in patients with type 2 diabetes mellitus. Current Medical Research and Opinion. 29(10). 1275–1286. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact